Extratemporal hypometabolism on FDG PET in temporal lobe epilepsy as a predictor of seizure outcome after temporal lobectomy
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
We investigated the relationship between the presence of extratemporal hypometabolism on fluorine-18 fluorodeoxyglucose positron emission tomography (FDG PET) and seizure outcome after temporal lobectomy in patients with medically intractable temporal lobe epilepsy (TLE). In 47 patients with intractable unilateral mesial TLE, regional metabolic changes on FDG PET images obtained during the 2 months preceding anterior temporal lobectomy were compared with postoperative seizure outcome. Postoperative seizure outcome was evaluated with a mean follow-up period of 6.1±0.6 years (range 5.2−7.2 years). Forty-two (89%) of the 47 patients achieved a good postoperative seizure outcome (Engel class I or II). All patients had hypometabolism in the temporal cortex ipsilateral to the epileptogenic region on FDG PET scans. Fourteen (78%) of the 18 patients with hypometabolism only in the ipsilateral temporal cortex were completely seizure free (Engel class Ia) after surgery. In contrast, five (45%) of the 11 patients with extratemporal cortical hypometabolism confined to the ipsilateral cerebral hemisphere and only four (22%) of the 18 patients with hypometabolism in the contralateral cerebral cortex were completely seizure free after surgery. The postoperative seizure-free rates were significantly different across the three groups of patients with different cortical metabolic patterns (P<0.005). Furthermore, all of the nine patients with a non-class I outcome (Engel class II−IV) had extratemporal (including contralateral temporal) cortical hypometabolism. Thalamic hypometabolism was noted in 20 (43%) of the 47 patients (ipsilateral in 12, bilateral in 8). Sixteen (59%) of the 27 patients with normal thalamic metabolism were completely seizure free after surgery, while only seven (35%) of the 20 patients with thalamic hypometabolism became completely seizure free (P<0.05). Multivariate analysis revealed that among variables including clinical, EEG, magnetic resonance imaging, pathological and FDG PET metabolic findings, only cortical metabolic pattern was an independent factor for the prediction of postoperative seizure outcome (P<0.005). It is concluded that extratemporal cortical hypometabolism outside the seizure focus, in particular hypometabolism in the contralateral cerebral cortex, may be associated with a poorer postoperative seizure outcome in TLE and may represent underlying pathology that is potentially epileptogenic. Thalamic hypometabolism, which was associated, but not independently, with a higher likelihood of postoperative seizures, may be secondary to extratemporal or temporal pathology.
- Theodore WH, Sato S, Kufta C, Balish MB, Bromfield EB, Leiderman DB. Temporal lobectomy for uncontrolled seizures: the role of positron emission tomography. Ann Neurol 1992; 32:789−794.
- Radtke RA, Hanson MW, Hoffman JM, et al. Temporal lobe hypometabolism on PET: predictor of seizure control after temporal lobectomy. Neurology 1993; 43:1088−1092.
- Manno EM, Sperling MR, Ding X, et al. Predictors of outcome after anterior temporal lobectomy: positron emission tomography. Neurology 1994; 44:2331−2336.
- Dupont S, Semah F, Clemenceau S, Adam C, Baulac M, Samson Y. Accurate prediction of postoperative outcome in mesial temporal lobe epilepsy: a study using positron emission tomography with18fluorodeoxyglucose. Arch Neurol 2000; 57:1331−1336.
- Swartz BE, Tomiyasu U, Delgado-Escueta AV, Mandelkern M, Khonsari A. Neuroimaging in temporal lobe epilepsy: test sensitivity and relationships to pathology and postoperative outcome. Epilepsia 1992; 33:624−634.
- Benbadis SR, So NK, Antar MA, Barnett GH, Morris HH. The value of PET scan (and MRI and Wada test) in patients with bitemporal epileptiform abnormalities. Arch Neurol 1995; 52:1062−1068.
- Blum DE, Ehsan T, Dungan D, Karis JP, Fisher RS. Bilateral temporal hypometabolism in epilepsy. Epilepsia 1998; 39:651−659.
- Sperling MR, Gur RC, Alavi A, et al. Subcortical metabolic alterations in partial epilepsy. Epilepsia 1990; 31:145−155.
- Khan N, Leenders KL, Hajek M, Maguire P, Missimer J, Wieser HG. Thalamic glucose metabolism in temporal lobe epilepsy measured with18F-FDG positron emission tomography (PET). Epilepsy Res 1997; 28:233−243.
- Newberg AB, Alavi A, Berlin J, Mozley PD, O'Connor M, Sperling M. Ipsilateral and contralateral thalamic hypometabolism as a predictor of outcome after temporal lobectomy for seizures. J Nucl Med 2000; 41:1964−1968.
- Engel J Jr, Van Ness PC, Rasmussen TB, Ojemann LM. Outcome with respect to epileptic seizures. In: Engel J Jr, ed. Surgical treatment of the epilepsies, 2nd edn. New York: Raven Press; 1993:609−621.
- Jeong S-W, Lee SK, Kim K-K, Kim H, Kim J-Y, Chung C-K. Prognostic factors in anterior temporal lobe resections for mesial temporal lobe epilepsy: multivariate analysis. Epilepsia 1999; 40:1735−1739.
- Morrell F, Smith MC, Detoledo-Morrell L. Secondary epileptogenesis and kindling. In: Wylie E, ed. The treatment of epilepsy: principles and practice. Philadelphia: Lea & Febiger; 1993:126−144.
- Goddard GV. The development of epileptic seizures through brain stimulation at low intensity. Nature 1967; 214:1020−1021.
- Fanelli RJ, McNamara JO. Effects of age on kindling and kindled seizure-induced increase of benzodiazepine receptor binding. Brain Res 1986; 362:17−22.
- DeToledo-Morrell L, Geinisman Y, Morrell F. Age-dependent alterations in hippocampal synaptic plasticity: relation to memory disorders. Neurobiol Aging 1988; 9:581−590.
- Cibula JE, Gilmore RL. Secondary epileptogenesis in humans. J Clin Neuropsychol 1997; 14:111−127.
- Blume W, Desai H, Girvin J, et al. Effectiveness of temporal lobectomy measured by yearly follow-up and multivariate analysis. J Epilepsy 1994; 7:203−214.
- Berg AT, Walczak T, Hirsch LJ, Spencer SS. Multivariable prediction of seizure outcome one year after resective epilepsy surgery: development of a model with independent validation. Epilepsy Res 1998; 29:185−194.
- Radhakrishnan K, So EL, Silbert PL, et al. Predictors of outcome of anterior temporal lobectomy for intractable epilepsy: a multivariate study. Neurology 1998; 51:465−471.
- Berkovic SF, McIntosh AM, Kalnins RM, et al. Preoperative MRI predicts outcome of temporal lobectomy: an actuarial analysis. Neurology 1995; 45:1358−1363.
- McIntosh AM, Wilson SJ, Berkovic SF. Seizure outcome after temporal lobectomy: current research practice and findings. Epilepsia 2001; 42:1288−1307.
- Drzezga A, Arnold S, Minoshima S, et al.18F-FDG PET studies in patients with extratemporal and temporal epilepsy: evaluation of an observer-independent analysis. J Nucl Med 1999; 40:737−746.
- Kim YK, Lee DS, Lee SK, Chung CK, Chung JK, Lee MC.18F-FDG PET in localization of frontal lobe epilepsy: comparison of visual and SPM analysis. J Nucl Med 2002; 43:1167−1174.
- Matheja P, Diehl B, Kuwert T, et al. Measurement of temporal asymmetries of glucose consumption using linear profiles: reproducibility and comparison with visual analysis. Nuklearmedizin 1998; 37:43−48.
- Duarte PS, Zhuang H, Couturier O, Alavi A. Does semi-quantitative analysis of FDG-PET have any additional value in the diagnosis of mesial temporal sclerosis? Arq Neuropsiquiatr 2001; 59:871−874.
- Extratemporal hypometabolism on FDG PET in temporal lobe epilepsy as a predictor of seizure outcome after temporal lobectomy
European Journal of Nuclear Medicine and Molecular Imaging
Volume 30, Issue 4 , pp 581-587
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- FDG PET
- Temporal lobe epilepsy
- Extratemporal hypometabolism
- Postoperative outcome
- Industry Sectors
- Author Affiliations
- A1. Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Ilwon-dong, Kangnam-ku, Seoul, 135-710, Korea
- A2. Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
- A3. Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea